GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Humanigen Inc (STU:0KB1) » Definitions » YoY Rev. per Sh. Growth

Humanigen (STU:0KB1) YoY Rev. per Sh. Growth : -85.71% (As of Mar. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Humanigen YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Humanigen's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2023 was -85.71%.

Humanigen's Revenue per Share for the three months ended in Mar. 2023 was €0.00.


Humanigen YoY Rev. per Sh. Growth Historical Data

The historical data trend for Humanigen's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Humanigen YoY Rev. per Sh. Growth Chart

Humanigen Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 671.43 -50.00

Humanigen Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.00 -6.67 -86.67 -86.67 -85.71

Humanigen YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Humanigen's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2022 )
=(Revenue per Share (A: Dec. 2022 )-Revenue per Share (A: Dec. 2021 ))/ | Revenue per Share (A: Dec. 2021 ) |
=(0.027-0.054)/ | 0.054 |
=-50.00 %

Humanigen's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2023 is calculated as:

YoY Rev. per Sh. Growth (Q: Mar. 2023 )
=(Revenue per Share (Q: Mar. 2023 )-Revenue per Share (Q: Mar. 2022 )) / | Revenue per Share (Q: Mar. 2022 )) |
=(0.002-0.014)/ | 0.014 |
=-85.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Humanigen YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Humanigen's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Humanigen (STU:0KB1) Business Description

Traded in Other Exchanges
N/A
Address
830 Morris Turnpike, 4th Floor, Short Hills, NJ, USA, 07078
Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005. It has one segment, which is related to the development of pharmaceutical products.

Humanigen (STU:0KB1) Headlines

No Headlines